Clicky

Bausch Health Companies Inc(BVF)

Description: Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.


Keywords: Biotechnology Pharmaceutical Life Sciences Pharmaceutical Products S&P/Tsx 60 Index Medical Device Medical Device Products Generic Pharmaceutical Products Dermatological Products Bausch Health Bausch & Lomb Gastroenterology Products Bausch Ista Pharmaceuticals Lomb

Home Page: www.bauschhealth.com

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
Phone: 514-744-6792


Officers

Name Title
Mr. Thomas J. Appio CEO & Director
Mr. Thomas G. Vadaketh Exec. VP & CFO
Mr. Mirza Dautbegovic Sr. VP & COO
Mr. John S. Barresi Sr. VP, Controller & Chief Accounting Officer
Dr. Robert F. Butz VP of Medical & Scientific Affairs
Mr. Arthur J. Shannon Sr. VP and Head of Investor Relations & Global Communications
Ms. Seana Carson Exec. VP & Gen. Counsel
Ms. Kathleen Fitzpatrick Sr. VP & Chief HR Officer
Dr. Tage Ramakrishna M.D. Chief Medical Officer and Pres of R&D
Mr. Jeff Hartness Sr. VP of Market Access, Commercial Operations & Gov. Affairs

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 1.9562
Trailing PE: 10.0197
Price-to-Book MRQ: 18.3421
Price-to-Sales TTM: 0.3211
IPO Date:
Fiscal Year End: December
Full Time Employees: 19600
Back to stocks